From 2002 to 2007, 103 patients with primary myelofibrosis or postessential thrombocythemia and polycythemia vera myelofibrosis and a median age of 55 years (range, 32-68 years) were included in a prospective multicenter phase 2 trial to determine efficacy of a busulfan (10 mg/kg)/fludarabine (180 mg/m 2)-based reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation from related (n = 33) or unrelated donors (n = 70). All but 2 patients (2%) showed leukocyte and platelet engraftment after a median of 18 and 22 days, respectively. Acute graft-versus-host disease grade 2 to 4 occurred in 27% and chronic graft-versus-host disease in 43% of the patients. Cumulative incidence of nonrelapse mortality at 1 year was 16% (95% confidence interval, 9%-23%) and significantly lower for patients with a completely matched donor (12% vs 38%; P = .003). The cumulative incidence of relapse at 3 years was 22% (95% confidence interval, 13%-31%) and was influenced by Lille risk profile (low, 14%; intermediate, 22%; and high, 34%; P = .02). The estimated 5-year event-free and overall survival was 51% and 67%, respectively. In a multivariate analysis, age older than 55 years (hazard ratio = 2.70; P = .02) and human leukocyte antigen-mismatched donor (hazard ratio = 3.04; P = .006) remained significant factors for survival. The study was registered atwww.clinicaltrials.gov as #NCT 00599547.
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis : a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation / N. Kröger, E. Holler, G. Kobbe, M. Bornhäuser, R. Schwerdtfeger, H. Baurmann, A. Nagler, W. Bethge, M. Stelljes, L. Uharek, H. Wandt, A. Burchert, P. Corradini, J. Schubert, M. Kaufmann, P. Dreger, G.G. Wulf, H. Einsele, T. Zabelina, H.M. Kvasnicka, J. Thiele, R. Brand, A.R. Zander, D. Niederwieser, T.M. de Witte. - In: BLOOD. - ISSN 0006-4971. - 114:26(2009 Dec), pp. 5264-5270.
|Titolo:||Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis : a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation|
|Settore Scientifico Disciplinare:||Settore MED/15 - Malattie del Sangue|
|Data di pubblicazione:||dic-2009|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1182/blood-2009-07-234880|
|Appare nelle tipologie:||01 - Articolo su periodico|